{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"OptiNose, Inc."},"Symbol":{"label":"Symbol","value":"OPTN"},"Address":{"label":"Address","value":"1020 STONY HILL ROAD,SUITE 300, YARDLEY, Pennsylvania, 19067, United States"},"Phone":{"label":"Phone","value":"+1 267 364-3500"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"OptiNose Inc is a US-based specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, utilizes a proprietary breath powered exhalation delivery system, to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825."},"CompanyUrl":{"label":"Company Url","value":"https://www.optinose.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"John C. Messina","title":"SVP-Clinical Development & Medical Affairs"},{"name":"Michael C. Berkey","title":"Vice President-Technical Operations"},{"name":"Ramy A. Mahmoud","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}